azomycin has been researched along with Cancer of Esophagus in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biemans, R; Dubois, LJ; Lambin, P; Lieuwes, NG; Marcus, D; Niemans, R; Spiegelberg, L; Theys, J; van Hoof, SJ; Verhaegen, F; Yaromina, A | 1 |
| Brans, B; Ceelen, W; De Vlieghere, E; De Vos, F; De Wever, O; Descamps, B; Goethals, I; Kersemans, K; Melsens, E; Pattyn, P; Vanhove, C | 1 |
| Berbée, M; Claessens, A; Dubois, LJ; Erdkamp, FL; Lambin, P; Larue, RT; Nap, M; Panth, KM; Peeters, SG; Schreurs, WM; Sosef, MN; Van De Voorde, L; van Elmpt, WJ; Warmerdam, FA | 1 |
| Cabrera, AR; Fu, Z; Ma, L; Sun, X; Xie, P; Yang, Y; Yu, J; Yue, J; Zhao, S; Zheng, J | 1 |
| Glatstein, E; Makuch, RW; Schwade, JG; Strong, JM | 1 |
| Ikeda, M; Irie, G; Kamata, R; Kaneda, K; Kikuchi, Y; Mikuriya, S; Mochizuki, S; Sakura, M; Sakurai, T; Watari, T | 1 |
| Mitsuhashi, N; Mogi, K; Nakajima, N; Niibe, H; Okazaki, A; Saito, K; Sakaino, K; Sudo, H; Suzuki, Y; Yonome, I | 1 |
| Abe, M; Dodo, Y; Ono, K; Takahashi, M | 1 |
| Asakawa, H; Hoshino, T; Watarai, J | 1 |
| Glatstein, E; Johnston, M; Kelly, B; Kinsella, TJ; Rowland, J; Schwade, JG | 1 |
| Bamberg, M; Scherer, E; Streffer, C; Tamulevicius, P | 2 |
| Moore, JL; Newman, H; Paterson, IC; Venables, S | 1 |
| Begg, AC; Geboes, K; Haustermans, K; Hofland, I; Raleigh, J; Van de Pavert, L; Varia, M | 1 |
| Balm, A; Begg, AC; Blommestijn, G; Delaere, P; Hofland, I; Janssen, H; Raleigh, JA; Sciot, R; Sprong, D; Van Velthuyzen, L; Varia, M | 1 |
7 trial(s) available for azomycin and Cancer of Esophagus
| Article | Year |
|---|---|
A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.
Topics: Adenocarcinoma; Cell Hypoxia; Chemoradiotherapy, Adjuvant; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophagectomy; Female; Humans; Male; Nitroimidazoles; Phosphoramide Mustards; Positron-Emission Tomography; Preoperative Care; Survival Analysis; Treatment Outcome | 2016 |
Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Esophageal Neoplasms; Half-Life; Humans; Injections, Intravenous; Kinetics; Metabolic Clearance Rate; Misonidazole; Nitroimidazoles; Osteosarcoma; Peripheral Nervous System Diseases; Probability | 1982 |
[Clinical evaluation of misonidazole combined with radiotherapy in the treatment of carcinoma of the esophagus--a double-blind randomized trial].
Topics: Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Misonidazole; Nitroimidazoles; Random Allocation | 1984 |
[Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
Topics: Aged; Esophageal Neoplasms; Female; Humans; Kidney; Lung Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Oxygen; Stomach Neoplasms; Tongue Neoplasms; Uterine Cervical Neoplasms | 1984 |
Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure.
Topics: Combined Modality Therapy; Esophageal Neoplasms; Humans; Injections, Intravenous; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1984 |
Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
Topics: Adult; Aged; Brain Neoplasms; Clinical Trials as Topic; Esophageal Neoplasms; Female; Glioma; Humans; Kinetics; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles | 1981 |
Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR.
Topics: Antibodies; Biopsy; Diffusion; Esophageal Neoplasms; Female; Head and Neck Neoplasms; Humans; Hypoxia; Idoxuridine; Kinetics; Male; Nitroimidazoles; Nucleic Acid Synthesis Inhibitors; Radiation-Sensitizing Agents; Rectal Neoplasms; Regional Blood Flow; Specimen Handling; Uterine Cervical Neoplasms | 2001 |
8 other study(ies) available for azomycin and Cancer of Esophagus
| Article | Year |
|---|---|
Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Esophageal Neoplasms; Female; Humans; Male; Mice; Nitroimidazoles; Phosphoramide Mustards; Radiation-Sensitizing Agents; Squamous Cell Carcinoma of Head and Neck | 2019 |
Hypoxia imaging with
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Cell Line, Tumor; Esophageal Neoplasms; Humans; Mice; Mice, Nude; Nimorazole; Nitroimidazoles; Positron Emission Tomography Computed Tomography; Radiation Tolerance; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2018 |
Measuring tumor hypoxia with ¹⁸F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Humans; Hypoxia; Logistic Models; Male; Middle Aged; Multimodal Imaging; Nitroimidazoles; Oxygen; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Clinical evaluation of radiosensitizing effects of misonidazole].
Topics: Brain Neoplasms; Combined Modality Therapy; Drug Evaluation; Esophageal Neoplasms; Humans; Lung Neoplasms; Misonidazole; Nitroimidazoles | 1984 |
[Clinical study on radiotherapy in combination with misonidazole].
Topics: Aged; Esophageal Neoplasms; Female; Humans; Lung Neoplasms; Middle Aged; Misonidazole; Neoplasms; Nitroimidazoles; Pharyngeal Neoplasms; Radiation-Sensitizing Agents | 1983 |
[Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Dexamethasone; Drug Interactions; Esophageal Neoplasms; Exanthema; Female; Glioma; Half-Life; Humans; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Nitroimidazoles; Phenytoin | 1981 |
Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Half-Life; Head and Neck Neoplasms; Humans; Kinetics; Misonidazole; Nitroimidazoles; Phenytoin; Time Factors | 1981 |
Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors.
Topics: Adenocarcinoma; Blood Vessels; Carcinoma, Squamous Cell; Cell Hypoxia; Diffusion; Esophageal Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Nitroimidazoles; Observer Variation; Radiation-Sensitizing Agents; Rectal Neoplasms; Reproducibility of Results; Uterine Cervical Neoplasms | 2000 |